Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $65.6 million.

  • Oncology Institute's Total Current Liabilities rose 4025.71% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.6 million, marking a year-over-year increase of 4025.71%. This contributed to the annual value of $52.2 million for FY2024, which is 5009.49% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Total Current Liabilities is $65.6 million, which was up 4025.71% from $64.8 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Total Current Liabilities ranged from a high of $65.6 million in Q3 2025 and a low of $171572.0 during Q1 2021
  • In the last 5 years, Oncology Institute's Total Current Liabilities had a median value of $33.5 million in 2023 and averaged $35.1 million.
  • In the last 5 years, Oncology Institute's Total Current Liabilities plummeted by 5611.17% in 2021 and then surged by 1827187.89% in 2022.
  • Oncology Institute's Total Current Liabilities (Quarter) stood at $29.8 million in 2021, then decreased by 0.26% to $29.7 million in 2022, then grew by 17.05% to $34.8 million in 2023, then skyrocketed by 50.09% to $52.2 million in 2024, then grew by 25.6% to $65.6 million in 2025.
  • Its last three reported values are $65.6 million in Q3 2025, $64.8 million for Q2 2025, and $59.5 million during Q1 2025.